We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Midatech Pharma PLC | NASDAQ:MTP | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.2851 | 0.284 | 0.30 | 0 | 01:00:00 |
It is proposed that this filing become effective under Rule 466:
|
⌧
|
immediately upon filing.
|
□
|
on (Date) at (Time)
|
Title of Each Class of
Securities to be Registered |
Amount to be
Registered |
Proposed Maximum
Aggregate Price Per Unit* |
Proposed Maximum
Aggregate Offering Price** |
Amount of
Registration Fee |
American Depositary Shares evidenced by American Depositary Receipts, each American Depositary Share representing twenty (20) ordinary shares of Midatech Pharma PLC
|
n/a
|
n/a
|
n/a
|
n/a
|
* Each unit represents one American Depositary Share.
** Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule
457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of receipts evidencing American Depositary Shares.
|
||||
Item 1. |
DESCRIPTION OF SECURITIES TO BE REGISTERED
|
Item 2.
|
AVAILABLE INFORMATION
|
Article (12)
|
Item 3. |
EXHIBITS
|
(a)(1) |
Form of Deposit Agreement by and among Midatech Pharma PLC, Deutsche Bank Trust Company Americas, as depositary (the “Depositary”), and all Holders and Beneficial Owners of American Depositary Shares evidenced by American
Depositary Receipts issued thereunder, including the form of American Depositary Receipt. – Previously filed as Exhibit (a) to Registration Statement on Form F-6/A (No. 333-207186), as amended, filed with the Securities and Exchange
Commission on October 27, 2015 and incorporated herein by reference.
|
(a)(2) |
Form of Amendment to Deposit Agreement (including the form of Depositary Receipt to be issued thereunder, attached as Exhibit A thereto). – Previously filed as Exhibit (a)(2) to Registration Statement on Form F-6 POS (No. 333-207186),
filed with the Securities and Exchange Commission on April 8, 2019 and incorporated by reference herein.
|
(a)(3) |
Form of Amendment No. 2 to Deposit Agreement (including the form of Depositary Receipt to be issued thereunder, attached as Exhibit A thereto). – Filed herewith as Exhibit (a)(3).
|
(b) |
Any other agreement to which the Depositary is a party relating to the issuance of the American Depositary Shares registered hereunder or the custody of the deposited securities represented thereby. – Not Applicable.
|
(c) |
Every material contract relating to the deposited securities between the Depositary and the Company in effect at any time within the last three years. – Not Applicable.
|
(d) |
Opinion of counsel to the Depositary as to the legality of the securities being registered. – Previously filed.
|
(e) |
Certification under Rule 466. – Filed herewith as Exhibit (e).
|
(f) |
Powers of Attorney for certain officers and directors and the authorized representative of the Company. – Previously filed and also as set forth on the signature pages hereto.
|
Item 4. |
UNDERTAKINGS
|
(a) |
The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the American Depositary Receipts, any reports and communications received from the issuer
of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities; and (2) made generally available to the holders of the underlying securities by the issuer.
|
(b) |
If the amounts of fees charged are not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver
promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an American Depositary Receipt 30 days before any change in the fee schedule.
|
Legal entity created by the Deposit Agreement, as amended, for the issuance of American Depositary Receipts evidencing American Depositary Shares, each representing a specified number of ordinary shares of
Midatech Pharma PLC
Deutsche Bank Trust Company Americas, solely in its capacity as Depositary
|
|||
By:
|
/s/ Michael Fitzpatrick | ||
Name:
|
Michael Fitzpatrick
|
||
Title:
|
Vice President
|
||
By:
|
/s/ Michael Curran | ||
Name:
|
Michael Curran
|
||
Title:
|
Vice President |
|
Midatech Pharma PLC
|
|
||
|
|
|
||
|
|
|
||
|
By:
|
/s/ Craig Cook
|
|
|
|
|
Name:
|
Craig Cook
|
|
|
|
Title:
|
Chief Executive Officer
|
|
Signatures
|
Capacity
|
/s/ Craig Cook
|
Chief Executive Officer and Director
|
Craig Cook
|
|
/s/ Stephen Stamp
|
Chief Financial Officer and Director
|
Stephen Stamp
|
|
|
Non-Executive Director
|
Dr. Huaizheng Peng
|
|
/s/ Rolf Stahel
|
Non-Executive Chairman of the Board
|
Rolf Stahel
|
|
|
Senior Independent Non-Executive Director
|
Simon Turton, Ph. D.
|
|
/s/ Sijmen de Vries, M.D.
|
Non-Executive Director
|
Sijmen de Vries, M.D.
|
|
|
Non-Executive Director
|
Frederic Duchesne
|
PUGLISI & ASSOCIATES
|
|
|
||
|
|
|
||
By:
|
/s/ Donald J. Puglisi
|
|
|
|
Name:
|
Donald J. Puglisi
|
|
|
|
Title:
|
Managing Director
|
|||
|
|
|
|
|
(a)(3)
|
Form of Amendment No. 2 to Deposit Agreement
|
(e)
|
Certification under Rule 466.
|
1 Year Midatech Pharma Chart |
1 Month Midatech Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions